Iwasa M, Sugimoto R, Takei Y

Idioma: Ingles.
Referencias bibliográficas: 7
Paginas: 407-408
Archivo PDF: 57.16 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Wunsch E, Naprawa G, Koziarska D, Milkiewicz M, Nowacki P, Milkiewicz P. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study. Ann Hepatol 2013; 12: 448-55.

2. Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, et al. Differential Impact of Hyponatremia and Hepatic Encephalopathy on Health- Related Quality of Life and Brain Metabolite Abnormalities in Cirrhosis. J Hepatol 2013; 59: 467-73.

3. Lemberg A, Fernández MA. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol 2009; 8: 95-102.

4. Sawara K, Kato A, Yoshioka Y, Suzuki K. Brain glutamine and glutamate levels in patients with liver cirrhosis: assessed by 3.0-T MRS. Hepatol Res 2004; 30: 18-23.

5. Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, et al. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 2008; 103: 1413-20.

6. Ginčs P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology 2008; 48: 1002-10.

7. Förster A, Nölte I, Wenz H, Al-Zghloul M, Kerl HU, Brockmann C, Brockmann MA, et al. Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology 2013; 55: 49-56